Influence of preservation method on histopathological lesions of kidney allografts

Annals of Transplantation

Volumn 14, Issue 1, 2009, Pages 10-13

  Kwiatkowski, Artur ^a   Wszoła, Michał ^a   Perkowska Ptasińska, Agnieszka ^a   Ostrowski, Krzysztof ^a   Domagala, Piotr ^a   Fesołowicz, Sławomir ^a   Trzebicki, Janusz ^a   Durlik, Magdalena ^a   Paczek, Leszek ^a   Rowiński, Wojciech ^a   Chmura, Andrzej ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Chronic rejection; Histopathologic changes; Long term results; Machine perfusion

Indexed keywords

CALCINEURIN INHIBITOR;

ACUTE GRAFT REJECTION; ADULT; ARTERIOLE; ARTERIOLE HYALINIZATION; ARTERIOSCLEROSIS; ARTICLE; ATROPHY; CADAVER KIDNEY; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; FIBROSING ALVEOLITIS; FOCAL GLOMERULOSCLEROSIS; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY INJURY; KIDNEY PRESERVATION; KIDNEY TUBULE; MACHINE PERFUSION; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; TUBULAR ATROPHY; ALLOTRANSPLANTATION; FIBROSIS; GRAFT REJECTION; IMMUNOLOGY; KIDNEY; KIDNEY TRANSPLANTATION; MIDDLE AGED; ORGAN PRESERVATION; PATHOLOGY; RISK FACTOR;

ADULT; CRYOPRESERVATION; FEMALE; FIBROSIS; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN PRESERVATION; RISK FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 67549102929     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Schold JD, Kaplan B, Baliga RS, Meier-Kriesche HU: The broad spectrum of quality in deceased donor kidneys. AmJ Transplant, 2005; 5(4 Pt 1): 757-65
2. Schilling M, Saunder A, Southard JH, Belzer FO: Long-term renal preservation and prevention of acute tubular necrosis by inhibitors of arachidonate metabolism. Transplant Proc, 1993; 25(4): 2534-35
3. Matsuno N, Sakurai E, Uchiyama M et al: Role of machine perfusion preservation in kidney transplantation from non-heartbeating donors. Clin Transplant, 1998; 12(1): 1-4
4. Schold JD, Kaplan B, Howard RJ, Reed Al, Foley DP: Are we frozen in time? Analysis of the utilization and efficacy of pulsatile perfusion in renal transplantation. AmJ Transpl, 2005; 5: 1681-88
5. Kwiatkowski A, Danielewicz R, Kosieradzki M et al: Six-year experience in continuous hypothermic pulsatile perfusion kidney preservation. Transplant Proc, 2001; 33(1-2): 913-15
6. Kwiatkowski A, Wszola M, Kosieradzki M et al: Machine perfusion improves renal allograft survival. Am] Transplant, 2007: 7: 1942-47
7. Pascual M, Theruvath T, Kawai T et al: Strategies to improve long-term outcomes after renal transplantation. N Engl J Med, 2002; 346(8): 580-90
8. Vallejos A, Alperovich G, Moreso F. et al: Resistive index and chronic allograft nephropathy evaluated in protocol biopsies as predictors of graft outcome. Nephrol Dial Transplant, 2005; 20(11): 2511-16.Epub2005Aug2
9. Solez K, Vincenti F, Filo RS: Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation, 1998; 66(12): 1736-40
10. Cosio FG, Grande JP, Larson TS et al: Kidney allograft fibrosis and atrophy early after living donor transplantation. AmJ Transplant, 2005; 5(5): 1130-36
11. Solez K, Colvin RB, Racusen LC et al: Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). AmJ Transplant, 2007; 7(3): 518-26
12. Halloran PF: Call for revolution: a new approach to describing allograft deterioration. AmJ Transplant, 2002; 2(3): 195-200
13. Polyak MM, Arrington BO, Stubenbord WT et al: The influence of pulsatile preservation on renal transplantation in the 1990s. Transplantation, 2000; 69(2): 249